{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:59:03Z","timestamp":1761512343328,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.seizure.2006.12.006","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T14:22:02Z","timestamp":1168266122000},"page":"271-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Levetiracetam monotherapy for children and adolescents with benign rolandic seizures"],"prefix":"10.1016","volume":"16","author":[{"given":"A.","family":"Verrotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Manco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ciambra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Iannetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Balestri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Franzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Chiarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1999","series-title":"Benign childhood partial seizures and related epileptic syndromes","author":"Panayiotopoulos","key":"10.1016\/j.seizure.2006.12.006_bib1"},{"key":"10.1016\/j.seizure.2006.12.006_bib2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0887-8994(01)00353-8","article-title":"Typical an atypical rolandic epilepsy in childhood: a follow-up study","volume":"26","author":"Verrotti","year":"2002","journal-title":"Pediatric Neurol"},{"key":"10.1016\/j.seizure.2006.12.006_bib3","doi-asserted-by":"crossref","unstructured":"Commission, on Classification and Terminology of the International League Against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30:389\u201399.","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"10.1016\/j.seizure.2006.12.006_bib4","series-title":"The epilepsies. Seizures, syndromes and management","first-page":"224","article-title":"Benign childhood epilepsy with centrotemporal spikes","author":"Panayiotopoulos","year":"2005"},{"key":"10.1016\/j.seizure.2006.12.006_bib5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0387-7604(94)90056-6","article-title":"Indication for anti-epileptic drug treatment of benign childhood epilepsy with centro-temporal spikes","volume":"16","author":"Hamada","year":"1994","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2006.12.006_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0387-7604(00)00127-3","article-title":"The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep","volume":"22","author":"Galanopoulou","year":"2000","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2006.12.006_bib7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1046\/j.1528-1157.2001.41300.x","article-title":"Pharmacokinetic study of Levetiracetam in children","volume":"42","author":"Pellock","year":"2001","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2006.12.006_bib8","first-page":"S9","article-title":"Antiepileptogenesis, neuroprotection and disease modification in the treatment of epilepsy: focus on Levetiracetam","volume":"5","author":"Klitgaard","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2006.12.006_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","article-title":"The novel antiepileptic drug Levetiracetam (UCB L059) appears to act via a specific binding site in CNS membranes","volume":"286","author":"Noyer","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.seizure.2006.12.006_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/PL00005097","article-title":"Levetiracetam (UCB L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission","volume":"356","author":"Birnstiel","year":"1997","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.seizure.2006.12.006_bib11","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The antiepileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA-and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.seizure.2006.12.006_bib12","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/seiz.2000.0504","article-title":"Levetiracetam does not modulate neuronal voltage-gated Na+and T-type Ca2+currents","volume":"10","author":"Zona","year":"2001","journal-title":"Seizures"},{"key":"10.1016\/j.seizure.2006.12.006_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.55.2.236","article-title":"Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial","volume":"55","author":"Cereghino","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2006.12.006_bib14","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1528-1157.2000.tb04605.x","article-title":"Efficacy and tolerability of Levetiracetam 3000mg in patients with refractorial partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group","volume":"41","author":"Ben-Menachem","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.12.006_bib15","first-page":"426","article-title":"A new antiepileptic drug","volume":"72","author":"Shorvon","year":"2002","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.seizure.2006.12.006_bib16","first-page":"77","article-title":"A systematic review of the safety profile of Levetiracetam: a new antiepileptic drug","volume":"47","author":"French","year":"2001","journal-title":"Epilepsy"},{"key":"10.1016\/j.seizure.2006.12.006_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0920-1211(01)00287-X","article-title":"Levetiracetam, oxocarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review","volume":"46","author":"Marson","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2006.12.006_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1528-1167.2006.00372.x","article-title":"Efficacy and Safety or Levetiracetam (up to 2000mg\/day) in Taiwanese Patients with Refractory Partial Seizures: a multicenter, randomized, double-blind, placebo-controlled study","volume":"47","author":"Tsai","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.12.006_bib19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1528-1157.2000.tb00323.x","article-title":"Multicenter double-blind, randomized, placebo-controlled trial of Levetiracetam as add-on therapy in patients with refractory partial seizures","volume":"41","author":"Shorvon","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.12.006_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.seizure.2005.02.004","article-title":"Efficacy and safety of Levetiracetam: an add-on trial in children with refractory epilepsy","volume":"14","author":"Grosso","year":"2005","journal-title":"Seizures"},{"key":"10.1016\/j.seizure.2006.12.006_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.seizure.2004.02.006","article-title":"Levetiracetam in refractory epilepsy: a prospective observational study","volume":"14","author":"Mohanraj","year":"2005","journal-title":"Seizures"},{"key":"10.1016\/j.seizure.2006.12.006_bib22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1059-1311(03)00004-9","article-title":"Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases","volume":"12","author":"Bello-Espinoza","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2006.12.006_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1090-3798(03)00079-5","article-title":"Rolandic epilepsy: a challenge in terminology and classification","volume":"7","author":"Lundberg","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2006.12.006_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1090-3798(03)00041-2","article-title":"Effect of levetiracetam in refractory childhood epilepsy syndromes","volume":"7","author":"Lage","year":"2003","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2006.12.006_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S1525-5050(03)00171-9","article-title":"Landau-Kleffner syndrome responsive to levetiracetam","volume":"4","author":"Kossoff","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2006.12.006_bib26","first-page":"901","article-title":"Atypical benign epilepsy of childhood with rolandic spikes: features of a subset requiring more than one medication for seizure control","volume":"17","author":"Al Twajri","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2006.12.006_bib27","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1528-1157.2002.13101.x","article-title":"Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial","volume":"43","author":"Glauser","year":"2002","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2006.12.006_bib28","first-page":"S45","article-title":"Preliminary efficacy of levetiracetam in children","volume":"5","author":"Glauser","year":"2003","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.seizure.2006.12.006_bib29","doi-asserted-by":"crossref","first-page":"558","DOI":"10.33588\/rn.3706.2003314","article-title":"Levetiracetam in children and adolescents with epilepsy","volume":"37","author":"Herranz","year":"2003","journal-title":"Revue Neurologie"},{"key":"10.1016\/j.seizure.2006.12.006_bib30","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1046\/j.1528-1157.2001.32101.x","article-title":"Levetiracetam psychosis in children with epilepsy","volume":"42","author":"Kossoff","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2006.12.006_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1059-1311(03)00111-0","article-title":"Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam","volume":"13","author":"Mula","year":"2004","journal-title":"Seizures"},{"key":"10.1016\/j.seizure.2006.12.006_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"63","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2006.12.006_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0920-1211(03)00080-9","article-title":"The Keeper trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study","volume":"54","author":"Morrell","year":"2003","journal-title":"Epilepsy Res"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913110600241X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105913110600241X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:35:44Z","timestamp":1761010544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105913110600241X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S105913110600241X"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2006.12.006","relation":{},"ISSN":["1059-1311"],"issn-type":[{"type":"print","value":"1059-1311"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam monotherapy for children and adolescents with benign rolandic seizures","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2006.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}